US 10568956
Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
granted A61KA61K2039/5258A61K2039/53
Quick answer
US patent 10568956 (Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
- Grant date
- Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/5258, A61K2039/53, A61K2039/57, A61K2039/575